Skip to main content
    P

    Progyny Inc (PGNY)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $36.18
    -0.40 (-1.09%)

    Market Cap: $2.66B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Progyny Inc (PGNY) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Progyny reported revenue of $1.29B for the fiscal year ended Dec 31, 2025, up 10.4% from the year before. That year, net income was $58.52M with a net margin of 4.5%, operating cash flow was $210.19M and free cash flow was $191.78M. The quarter ended Sep 30, 2026 had revenue of $341.25M and net income of $26.25M.

    Revenue and Margins

    The operating margin was 6.6% in the fiscal year ended Dec 2025, the highest of the 9 years shown. Over the 8 years to Dec 2025, revenue grew from $48.58M, a compound annual rate of 50.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.29B+10.4%23.6%6.6%4.5%
    Dec 2024$1.17B+7.2%21.7%5.8%4.7%
    Dec 2023$1.09B+38.3%21.9%5.7%5.7%
    Dec 2022$786.91M+57.2%21.3%3.0%3.9%
    Dec 2021$500.62M+45.2%22.4%6.5%13.1%
    Dec 2020$344.86M+50.1%20.3%2.4%13.5%
    Dec 2019$229.68M+117.9%19.8%4.2%-3.7%
    Dec 2018$105.40M+116.9%18.4%-3.3%0.6%
    Dec 2017$48.58MN/A15.2%-22.7%-25.6%
    Annual, fiscal years ended Dec 2017 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 7.7% from the year before. In the quarter ended Sep 2026, net income rose 89.4% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Revenue$1.29B$1.17B$1.09B$786.91M$500.62M$344.86M$229.68M$105.40M$48.58M
    Cost of revenue$984.18M$913.86M$849.80M$619.59M$388.49M$274.80M$184.18M$85.97M$41.18M
    Gross profit$304.48M$253.36M$238.80M$167.32M$112.14M$70.06M$45.51M$19.43M$7.40M
    Operating income$85.28M$67.45M$62.18M$23.34M$32.34M$8.35M$9.68M-$3.45M-$11.01M
    Net income$58.52M$54.34M$62.04M$30.36M$65.77M$46.46M-$8.57M$661.00K-$12.45M
    EBITDA$100.38M$86.38M$72.97M$26.04M$33.27M$10.46MN/AN/AN/A
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$341.25M$350.51M$328.50M$318.40M$313.35M$332.87M$324.04M$298.43M$286.63M$304.09M$278.08M$269.94M
    Gross profit$83.74M$89.30M$83.07M$76.88M$72.83M$78.97M$75.80M$63.43M$59.24M$68.28M$62.41M$56.89M
    Operating income$35.18M$40.00M$35.38M$15.22M$21.53M$24.36M$24.17M$15.79M$12.46M$20.69M$18.52M$13.80M
    Net income$26.25M$28.05M$24.23M$12.48M$13.86M$17.11M$15.06M$10.53M$10.42M$16.48M$16.90M$13.47M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $3.73M by $108.51M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Total assets$742.43M$607.10M$756.62M$542.99M$358.06M$253.93M$150.43M$41.32M$34.96M
    Current assets$551.77M$472.72M$640.41M$433.86M$258.54M$190.22M$132.44M$24.54M$16.77M
    Cash and equivalents$112.24M$162.31M$97.30M$120.08M$91.41M$70.31M$80.38M$127.00K$4.69M
    Total liabilities$226.39M$185.04M$203.19M$166.02M$106.24M$86.98M$36.16M$30.20M$24.27M
    Short-term debt$3.73M$2.86M$2.15M$1.23M$1.23M$1.23MN/A$253.00K$3.56M
    Long-term debtN/AN/AN/AN/AN/AN/AN/AN/A$1.63M
    Shareholder equity$516.04M$422.06M$553.43M$376.97M$251.82M$166.95M$114.27M-$95.11M$10.69M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$675.79M$715.84M$698.34M$742.43M$795.23M$760.95M$730.28M$607.10M$659.97M$698.63M$794.30M$756.62M
    Total liabilities$261.76M$262.58M$258.99M$226.39M$235.22M$245.93M$263.13M$185.04M$225.10M$242.44M$222.70M$203.19M
    Cash and equivalents$116.82M$152.63M$131.61M$112.24M$133.98M$132.51M$109.24M$162.31M$91.48M$94.96M$114.96M$97.30M
    Shareholder equity$414.03M$453.26M$439.34M$516.04M$560.00M$515.02M$467.16M$422.06M$434.88M$456.19M$571.60M$553.43M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 91.2% of operating cash flow. Share repurchases came to 42.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Operating cash flow$210.19M$179.10M$188.81M$80.39M$26.04M$36.20M-$1.53M$2.27M-$9.47M
    Capital expenditures$18.41M$5.41M$3.64M$3.24M$2.13M$1.04M$2.96M$579.00K$612.00K
    Free cash flow$191.78M$173.70M$185.17M$77.15M$23.91M$35.17M-$4.49M$1.69M-$10.09M
    Share repurchases$81.66M$300.28M$0$0N/A$892.00K$3.02M$1.21M$0
    Investing cash flow-$159.01M$195.79M-$200.53M-$43.87M$8.77M-$40.03M-$2.76M$1.90M-$612.00K
    Financing cash flow-$99.36M-$309.88M-$11.07M-$7.86M-$13.70M-$6.25M$84.55M-$8.74M$11.77M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$56.60M$50.42M$45.95M$54.20M$50.67M$55.51M$49.81M$52.16M$44.52M$56.69M$25.73M$37.66M
    Capital expenditures$9.37M$6.22M$6.35M$5.61M$4.68M$5.27M$2.84M$1.90M$1.79M$866.00K$850.00K$553.00K
    Free cash flow$47.24M$44.21M$39.60M$48.59M$45.99M$50.24M$46.97M$50.27M$42.72M$55.83M$24.88M$37.11M
    Last 12 quarters

    Frequently Asked Questions About PGNY

    What is Progyny's annual revenue?

    Progyny reported revenue of $1.29B for the fiscal year ended Dec 31, 2025.

    How fast is Progyny's revenue growing?

    Revenue was up 10.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 17.9%.

    Is Progyny profitable?

    Yes. Progyny reported net income of $58.52M for the fiscal year ended Dec 31, 2025, with a net margin of 4.5%.

    How much free cash flow does PGNY generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $210.19M minus capital expenditures of $18.41M produced free cash flow of $191.78M.

    How much debt does Progyny have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $3.73M and cash and equivalents of $112.24M.